Mission Statement, Vision, & Core Values of Daré Bioscience, Inc. (DARE)

Ever wondered what drives a biopharmaceutical company focused on women's health? What are the guiding principles behind Daré Bioscience's mission to innovate and address unmet needs? Understanding their mission, vision, and core values provides insight into their strategic direction and commitment to women's well-being. How does this translate into their financial performance, considering their $26 million market cap as of April 2025 and a trailing 12-month revenue of $9.8K as of December 2024?

Let's delve into the core of Daré Bioscience to uncover the values that shape their pursuit of innovation in women's health.

Daré Bioscience's mission is to challenge the status quo, making women's health a priority. They aim to accelerate innovation in women's health, ensuring science-backed treatments are accessible and trusted. The company strives to address decades of unmet needs by bringing to market innovative, evidence-based solutions primarily in contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health, and menopause.

Daré Bioscience's vision is to meet the increasing demand for evidence-based solutions with both uncompromising scientific rigor and rapid, responsible commercialization. They leverage existing clinical proof of concept and safety data to expedite the availability of potential products.

Daré Bioscience's core values are:

• Genuine, respectful, authentic, and ethical conduct.
• Valuing each other and acting in the best interest of Daré.
• Achieving success through integrity.
• Daring and courageous convictions.
• Open-mindedness and receptivity to ideas.
• Continuous self-improvement and process refinement.

Daré Bioscience, Inc. (DARE) An Overview of

Daré Bioscience, Inc. (DARE) is a biopharmaceutical company focused on the development and marketing of innovative products for women's health. Founded with the vision of addressing unmet needs in this specialized area, the company has dedicated itself to creating solutions that can improve the lives of women. As of April 2025, Daré Bioscience continues to advance its pipeline of novel therapies and technologies.

The company’s portfolio includes products and product candidates designed to address a broad range of conditions, including contraception, vaginal health, and sexual health. Among their key offerings is XACIATO™, a vaginal gel indicated for the treatment of bacterial vaginosis in female patients 12 years and older. Additionally, Daré is involved in the development of Ovaprene®, a hormone-free contraceptive vaginal ring, and other innovative therapies aimed at improving women's health outcomes.

Financially, Daré Bioscience has demonstrated both progress and challenges. According to their financial results for the year ended December 31, 2024, the company reported total revenues of $13.2 million, primarily driven by sales of XACIATO™. Despite these revenues, the company experienced a net loss of $48.3 million, reflecting significant investments in research and development, as well as selling, general, and administrative expenses. As of December 31, 2024, Daré Bioscience held cash and cash equivalents totaling $21.3 million. These figures illustrate the financial dynamics of a growing biopharmaceutical company focused on innovation and market expansion.

Daré Bioscience's commitment to women's health is evident in its strategic focus and innovative product pipeline. The company operates in a competitive landscape, striving to establish itself as a leader in the women's health sector. The company's recent achievements and financial performance offer valuable insights into its potential and challenges.

To delve deeper into understanding Daré Bioscience, Inc. (DARE) and its position in the market, consider exploring additional resources:

Daré Bioscience, Inc. (DARE) Mission Statement of

Daré Bioscience, Inc. (DARE) is dedicated to the development and marketing of innovative products and therapies that enhance women's health. Their mission is centered around identifying, developing, and bringing to market differentiated products that address unmet needs in contraception, vaginal health, sexual health, and fertility. The company focuses on becoming a leader in women's health innovation, improving the lives of women worldwide. You might also be interested in: Exploring Daré Bioscience, Inc. (DARE) Investor Profile: Who’s Buying and Why?

The core components of Daré Bioscience's mission statement can be broken down into several key areas:

• Focus on Women's Health: Daré Bioscience is exclusively dedicated to addressing women's health issues. This specialization allows them to concentrate their resources and expertise on a specific segment of the healthcare market, fostering deep insights and targeted solutions.
• Innovation and Differentiation: The company emphasizes the development of innovative and differentiated products. This suggests a commitment to going beyond existing solutions, creating novel therapies, and improving upon current treatments.
• Addressing Unmet Needs: A core part of their mission involves identifying and fulfilling unmet needs in various areas of women's health. This implies a strong focus on research and development to discover gaps in the market and create products that cater to these underserved areas.
• Improving Lives Worldwide: Daré Bioscience aims to have a global impact by improving the lives of women worldwide. This suggests an ambition to expand their market reach and make their products accessible to women across different regions and socioeconomic backgrounds.

These components collectively drive Daré Bioscience's strategic initiatives and product development efforts. For instance, their focus on unmet needs is exemplified by products like XACIATO™ (clindamycin phosphate vaginal gel, 2%) indicated for the treatment of bacterial vaginosis in female patients 12 years and older, highlighting their commitment to addressing prevalent yet often overlooked conditions. This FDA-approved product underscores their dedication to delivering high-quality, effective solutions.

Furthermore, Daré Bioscience's pipeline includes other innovative products aimed at various aspects of women's health, such as:

• Contraception: Developing novel contraceptive options to provide women with more choices and control over their reproductive health.
• Vaginal Health: Creating products to prevent and treat common vaginal infections and conditions, improving overall vaginal health and well-being.
• Sexual Health: Addressing sexual dysfunction and enhancing sexual wellness through innovative therapies.
• Fertility: Developing solutions to assist women facing fertility challenges, helping them achieve their family planning goals.

Daré Bioscience's commitment to innovation is further supported by their strategic collaborations and partnerships with leading research institutions and pharmaceutical companies. As of the fiscal year 2024, Daré Bioscience reported total operating expenses of $41.3 million, with research and development expenses accounting for a significant portion. This financial commitment underscores their dedication to advancing scientific knowledge and developing cutting-edge products.

In summary, Daré Bioscience’s mission statement reflects a comprehensive approach to women's health, emphasizing innovation, addressing unmet needs, and improving lives globally. This mission is underpinned by strategic investments in research and development, as well as collaborations aimed at bringing novel and effective solutions to the market.

Daré Bioscience, Inc. (DARE) Vision Statement of

Daré Bioscience, Inc. (DARE) is a biopharmaceutical company committed to the development and marketing of innovative products for women's health. Understanding the company's mission, vision, and core values provides critical insight into its strategic direction and operational focus. These elements collectively define the company's purpose, desired future state, and guiding principles.

Mission Statement

Daré Bioscience's mission is to identify, develop, and bring to market innovative products and therapies that improve women's health, address unmet needs, and expand treatment options. This mission is reflected in their strategic focus on:

• Developing novel therapies: Focusing on innovative solutions for prevalent and underserved conditions.
• Addressing unmet needs: Targeting areas where current treatments are inadequate or non-existent.
• Expanding treatment options: Providing women and healthcare providers with a broader range of choices.

As of the fiscal year 2024, Daré Bioscience reported a net loss of $47.7 million, highlighting the financial challenges inherent in pharmaceutical development. However, this underscores the critical need for their mission to deliver cost-effective and accessible solutions. For more insights into the company's financial health, you can explore Breaking Down Daré Bioscience, Inc. (DARE) Financial Health: Key Insights for Investors.

Vision Statement

The vision of Daré Bioscience is to be a leader in women's health innovation, recognized for its commitment to improving women's lives through the development and commercialization of groundbreaking products. Key components of this vision include:

• Innovation leadership: Striving to be at the forefront of women's health advancements.
• Commitment to women's health: Dedication to addressing the unique healthcare needs of women.
• Groundbreaking products: Developing and delivering novel therapies that transform treatment paradigms.

Daré Bioscience's forward-looking statements in their 2024 annual report emphasize their commitment to continued innovation. These statements reflect the company's optimism and strategic intent to bring new and effective products to market, despite the financial risks associated with research and development.

Core Values

Daré Bioscience's core values guide its operations and decision-making, ensuring alignment with its mission and vision. These values typically include:

• Integrity: Conducting business with the highest ethical standards.
• Innovation: Fostering a culture of creativity and continuous improvement.
• Collaboration: Working together with partners and stakeholders to achieve common goals.
• Patient-centricity: Prioritizing the needs and well-being of women in all endeavors.

These core values are evident in Daré Bioscience's partnerships and collaborations, such as their licensing agreement with Organon for potential sales milestones up to $180 million plus royalties, aimed at expanding access to innovative products. Such collaborations reflect the company's commitment to working with others to maximize its impact on women's health.

Daré Bioscience, Inc. (DARE) Core Values of

While specific, formally declared core values for Daré Bioscience, Inc. are not explicitly available in my search results, we can infer the company's values from their mission, vision, and activities. Daré Bioscience is dedicated to identifying, developing, and bringing to market innovative products for women's health. This commitment suggests several core values that guide their operations and strategic decisions.

Based on the company's activities and focus, likely core values include:

• Innovation: A commitment to developing novel solutions.
• Women's Health Focus: Prioritizing the unique healthcare needs.
• Integrity: Adhering to high ethical standards.
• Collaboration: Working with partners.
• Patient-Centricity: Focusing on improving women's lives.

Here's a deeper look at how these inferred values might manifest in Daré Bioscience's work:

Innovation

Innovation is likely a core value for Daré Bioscience, given its focus on developing novel solutions for women's health. This is evident in their pipeline of products, which includes:

• Ovaprene: A hormone-free monthly vaginal contraceptive.
• Sildenafil Cream, 3.6%: For female sexual arousal disorder (FSAD).
• DARE-HRT1: A hormone therapy product to treat vasomotor symptoms (VMS) due to menopause.

These products address unmet needs in women's health and represent innovative approaches to contraception, sexual dysfunction, and hormone therapy.

Women's Health Focus

Daré Bioscience's commitment to women's health is central to its mission. This focus drives the company's strategic decisions and product development efforts. For example, Daré Bioscience has been actively involved in:

• Advancing Ovaprene through clinical trials to provide women with a hormone-free contraceptive option.
• Developing Sildenafil Cream, 3.6%, to address FSAD, a condition that affects a significant percentage of women.
• Working on DARE-HRT1 to provide a new option for women experiencing VMS during menopause.

Integrity

While direct mentions of integrity as a core value are not explicitly stated, it is implied through their commitment to regulatory compliance and ethical conduct in clinical trials and product development. Integrity is crucial in the pharmaceutical industry, where patient safety and data accuracy are paramount.

Collaboration

Collaboration appears to be another key value, as Daré Bioscience often partners with other organizations to advance its product pipeline. For instance, they have collaborated with:

• The National Institute of Child Health and Human Development (NICHD), a part of the National Institutes of Health (NIH), to support the development of Ovaprene.
• Various clinical research organizations to conduct clinical trials for their products.

These collaborations enable Daré Bioscience to leverage external expertise and resources, accelerating the development and commercialization of its products.

Patient-Centricity

Patient-centricity is evident in Daré Bioscience's focus on developing products that address unmet needs and improve the quality of life for women. This value is reflected in their efforts to:

• Provide women with hormone-free contraceptive options through Ovaprene.
• Offer a potential treatment for FSAD with Sildenafil Cream, 3.6%.
• Develop a new hormone therapy product for menopausal symptoms with DARE-HRT1.

By prioritizing the needs and preferences of women, Daré Bioscience aims to make a meaningful difference in their health and well-being.

To gain more insights into the company's financial performance, you might find this resource helpful: Breaking Down Daré Bioscience, Inc. (DARE) Financial Health: Key Insights for Investors